@xconomy.com 5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com 5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan